Federal grants to Healthpartners Institute
Healthpartners Institute in Minneapolis, Minnesota received $47.8 million in federal grants from fiscal 2021 to 2025, across 23 awards. Its largest program was Cancer Control, with $19.7 million. In fiscal 2025 it was awarded $9.8 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$47.8 million
- Awards23
- Awarded in FY 2025$9.8 million
- Largest award$19.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $8.7 million |
| FY 2022 | 10 | $9.4 million |
| FY 2023 | 11 | $9.3 million |
| FY 2024 | 12 | $10.6 million |
| FY 2025 | 9 | $9.8 million |
Programs that fund Healthpartners Institute
| Program | Awards | Amount |
|---|---|---|
| Cancer Control | 1 | $19.7 million |
| Child Health and Human Development Extramural Research | 3 | $6.3 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 2 | $5.8 million |
| Aging Research | 5 | $5.8 million |
| Cancer Cause and Prevention Research | 2 | $3.7 million |
| Research on Healthcare Costs, Quality and Outcomes | 2 | $2.0 million |
| Cardiovascular Diseases Research | 1 | $1.3 million |
| Oral Diseases and Disorders Research | 3 | $1.3 million |
| Social, Behavioral, and Economic Sciences | 1 | $995,110 |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $556,160 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 22 | $46.8 million |
| National Science Foundation | 1 | $995,110 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Metro-Minnesota community clinical oncology program (mm-ccop) | Cancer Control | July 30, 2021 | $19.7 million |
| A technology-driven intervention to improve early detection and management of cognitive impairment - project summary the prevalence of alzheimer’s disease (AD) and ad-related dementias (ADRD) is expected to triple by 2050, contributing to decreased quality of life, increased medical care utilization | Aging Research | August 31, 2022 | $3.8 million |
| Reducing clinical inertia in obesity management of diabetes in primary care: cluster-randomized trial - project summary obesity has been steadily increasing in prevalence and now affects more than 4 in 10 U.S. Adults, leading to many adverse health outcomes including myocardial infarction, stroke, t | Diabetes, Digestive, and Kidney Diseases Extramural Research | April 19, 2021 | $3.4 million |
| Treatment initiation for new episodes of depression in pregnant women - project summary up to 12% of pregnant women have a new episode of depression, ie, an incident or recurrent depressive episode with symptom onset during pregnancy. Effects of untreated antenatal depression include unhealthy mater | Child Health and Human Development Extramural Research | May 6, 2021 | $3.1 million |
| Mitigating diabetic ketoacidosis in people with T1D and chronic kidney disease on an SGLT1&2 inhibitor: ketosis risk factor determination and incorporation into an enhanced glucose ketone report - project summary it is estimated that 1.8 million people in the U.S. Have type 1 diabetes (T1D) and of t | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 22, 2025 | $2.4 million |
| The interplay of ends and tobacco control policy: impact on the population harms of tobacco - project summary this project will clarify the value and impact of policy options intended to reduce the population harms of tobacco. The rise in popularity of electronic nicotine delivery systems (ENDS) suc | Cancer Cause and Prevention Research | June 28, 2022 | $2.3 million |
| Maternal COVID-19 vaccination and lactation outcomes - the efficacy of coronavirus disease (COVID-19) vaccines available in the us is up to 95% against symptomatic COVID-19. However, pregnant and lactating individuals were excluded from initial clinical trials. COVID-19 vaccine trials are now underw | Child Health and Human Development Extramural Research | June 20, 2022 | $1.8 million |
| Improving recognition and management of hypertension in youth: comparing approaches for extending effective cds for use in a large rural health system | Research on Healthcare Costs, Quality and Outcomes | December 3, 2020 | $1.6 million |
| Neonatal, lactation, and child health outcomes following rsv vaccination during pregnancy - project summary respiratory syncytial virus (RSV) can cause severe illness in young children and is the leading cause of infant hospitalization in the united states. Prenatal rsv prefusion f protein−based (rs | Child Health and Human Development Extramural Research | August 9, 2024 | $1.4 million |
| A team-based and technology driven adherence intervention to improve chronic disease outcomes | Cardiovascular Diseases Research | February 5, 2021 | $1.4 million |
Questions people ask
How much federal grant money does Healthpartners Institute get?
$47.8 million in 23 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Healthpartners Institute the most?
The Department of Health and Human Services, with $46.8 million in 22 awards. The National Science Foundation follow.
What is Healthpartners Institute's largest federal grant?
$19.7 million under Cancer Control, with its first action in the period on July 30, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Healthpartners Institute?
Its largest are Cancer Control, Child Health and Human Development Extramural Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Minneapolis
- Minnesota Department of Education
- Regents of the University of Minnesota
- Metropolitan Council Minnesota
- MN Department of Employment & Economic Development
- Metropolitan Airports Commission
- Serveminnesota
- Minneapolis Public Housing Authority
- Xcel Energy Services Inc.
Largest federal grant recipients in Minnesota · Federal grants in Minnesota